Centiva Capital, LP Axonics, Inc. Transaction History

Centiva Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$66.47 - $69.65 $1.04 Million - $1.09 Million	-15,700 Reduced 17.44%	74,300 $5 Million
Q1 2024 May 15, 2024	BUY	$56.67 - $69.36 $4.69 Million - $5.73 Million	82,678 Added 1129.17%	90,000 $6.21 Million
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $361,560 - $466,777	7,322 New	7,322 $455,000
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $259,673 - $325,796	5,411 New	5,411 $273,000

235

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.